Table 2. National guidelines regarding general measures of COVID-19 prevention in oncology in the MENA region.
| Recommended measures | AL | EG | IQ | JO | K.S.A | KW | LB | MR | OM | SY | TN | UAE | YE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient management | |||||||||||||
| Screening of COVID-19 symptoms before clinic (outpatients) visit | + | + | + | + | + | + | + | + | + | - | + | - | - |
| Screening of COVID-19 symptoms before admission of patients | + | + | + | + | + | + | + | + | + | + | + | + | - |
| Providing surgical masking for all patients | + | + | - | + | + | + | + | + | + | + | + | + | - |
| Postponing routine follow up visits | - | + | + | + | + | + | + | + | + | + | + | + | - |
| Implementing call centres to triage patients | + | - | + | + | + | + | + | + | + | - | + | - | - |
| HCW management | |||||||||||||
| Favouring tumour board meetings based on videoconferencing | + | + | - | + | + | + | + | + | + | - | + | - | - |
| Educating HCW to adhere to standard precautions | + | + | + | + | + | + | + | + | + | + | + | + | - |
| Recommending HCW to: | |||||||||||||
| Wear a mask during consultations | + | + | + | + | + | + | + | + | + | + | + | + | |
| Disinfect hands regularly | + | + | + | + | + | + | + | + | + | + | + | + | - |
| N95 fitting | + | + | + | - | + | + | + | - | + | + | + | + | - |
| Staff clustering | - | - | + | - | + | + | - | - | + | - | + | - | - |
| Facility management | |||||||||||||
| Restricting visitors | + | + | - | + | + | + | + | + | + | + | + | + | |
| Establishing screening and triage stations at entrance of cancer centres units | + | + | + | + | + | + | + | + | + | - | + | - | - |
| Keeping distance of 1.5 m between each two patients | + | + | - | + | + | + | + | + | + | + | + | + | - |
| Disinfecting any instrument used after the examination of each patient | + | + | - | + | + | + | + | + | + | + | + | + | - |
| Disinfecting work surfaces regularly | + | + | - | + | + | + | + | + | + | + | + | + | - |
| Establishing a plan of action for suspected cases | + | + | + | + | + | + | + | + | + | + | + | + | - |
| Testing for COVID-19 | |||||||||||||
| Real time PCR and chest CT scan | + | + | + | + | * | + | + | + | + | - | + | - | - |
| Specifying whom to test | + | + | + | + | * | + | + | + | + | - | + | - | - |
| Specifying what to do with cancer patients with positive test | + | - | + | + | + | + | + | + | + | + | + | + | - |
AL: Algeria, EG: Egypt, IQ: Iraq, JO: Jordan, KW: Kuwait, LB: Lebanon, MR: Morocco, OM: Oman, K.S.A: Saudi Arabia, SY: Syria, TN: Tunisia, UAE: United Arab Emirates, YE: Yemen
+: Item discussed in the country guidelines, -: Item non discussed in the guidelines